Obstet Gynecol Sci.  2015 Jul;58(4):331-332. 10.5468/ogs.2015.58.4.331.

Comment on: Endometrial cancer occurrence five years after breast cancer in BRCA2 mutation patient

Affiliations
  • 1Comprehensive Gynecologic Cancer Center, Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, Korea. oursk79@cha.ac.kr

Abstract

No abstract available.


MeSH Terms

Breast Neoplasms*
Endometrial Neoplasms*
Female
Humans

Reference

1. Oh SE, Kim SH, Kim MS, Kim MK. Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patient. Obstet Gynecol Sci. 2015; 58:175–178.
2. Radice P, De Summa S, Caleca L, Tommasi S. Unclassified variants in BRCA genes: guidelines for interpretation. Ann Oncol. 2011; 22:Suppl 1. i18–i23.
3. National Human Genome Research Institute. National Institutes of Health. Breast Cancer Information Core: an open access on-line breast cancer mutation data base [Internet]. Bethesda (MD): National Human Genome Research Institute;2015. cited 2015 May 29. Available from: http://research.nhgri.nih.gov/projects/bic/.
4. Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, et al. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol. 2001; 80:395–398.
Full Text Links
  • OGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr